Developing a non-biopsy protocol for the female cohort 25-29 years with clinically typical fibroadenoma conforming to Maxwell criteria on ultrasound – Our peninsular experience in Wirral

2021 ◽  
Vol 47 (1) ◽  
pp. e12
Author(s):  
Tahera Arif ◽  
Raman Vinayagam
2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
T Arif ◽  
R Vinayagam

Abstract Introduction The aim of this study was to introduce a non –biopsy protocol in our department for benign breast lump referrals confirmed as typical U2/3 fibroadenoma on imaging. Current UK guidance is not to biopsy sonographically typical fibroadenoma in women under 25 years. We have studied our population extending the radiological Maxwell criteria reflecting benign outcomes in 25-29 years cohort. Method Retrospectively data was collected of all women between 25-29 years of age undergoing core biopsies for ultrasound confirmed fibroadenoma between 2014 and 2019 over a period of five years. The number of cancers picked up was compared with the number of referrals and the discordance between radiological diagnosis of fibroadenoma and histopathological confirmation of malignancy was recorded. Results A total of 1707 referrals were made across five years. n = 175 image guided core biopsies were carried out for U2, U3, U4 lesions appearing as fibroadenoma on ultrasound. Out of these (n = 175), all lesions coded U2/3 (n = 165) based on Maxwell criteria on ultrasound were negative for cancer. U4 lesions on ultrasound were confirmed as cancers mimicking fibroadenoma(n = 10). Conclusions This retrospective audit of 1707 patients provides sound evidence for non-biopsy of typical fibroadenoma in 25–29 years cohort sonographic features meet strict criteria.


2020 ◽  
Vol 96 (1) ◽  
Author(s):  
Justin K. Niles ◽  
Hope E. Karnes ◽  
Jeffrey S. Dlott ◽  
Harvey W. Kaufman

2007 ◽  
Vol 52 (2) ◽  
pp. 430-435 ◽  
Author(s):  
Guillaume Guichard ◽  
Stéphane Larré ◽  
Andrea Gallina ◽  
Adi Lazar ◽  
Hugo Faucon ◽  
...  

2008 ◽  
Vol 179 (2) ◽  
pp. 504-507 ◽  
Author(s):  
Vincent Ravery ◽  
Sébastien Dominique ◽  
Xavière Panhard ◽  
Marianne Toublanc ◽  
Liliane Boccon-Gibod ◽  
...  

2011 ◽  
Vol 10 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Lucas Lembrança ◽  
Jéssica Medina ◽  
Marcelo Portugal ◽  
Delvone Almeida ◽  
Jorge Solla ◽  
...  

2019 ◽  
Vol 29 (7) ◽  
pp. 910-916
Author(s):  
Patrick D. Evers ◽  
Neal Jorgensen ◽  
Borah Hong ◽  
Erin Albers ◽  
Mariska Kemna ◽  
...  

AbstractBackground:Significant inter-centre variability in the intensity of endomyocardial biopsy surveillance for rejection following paediatric cardiac transplantation has been reported. Our aim was to determine if low-intensity biopsy surveillance with two scheduled biopsies in the first year would produce outcomes similar to published registry outcomes.Methods:A retrospective study of paediatric recipients transplanted between 2008 and 2014 using a low-intensity biopsy protocol consisting of two surveillance biopsies at 3 and 12–13 months in the first post-transplant year, then annually thereafter. Additional biopsies were performed based on echocardiographic and clinical surveillance. Excluded were recipients that were re-transplanted or multi-organ transplanted or were followed at another institution.Results:A total of 81 recipients in the first 13 months after transplant underwent an average of 2 (SD ± 1.3) biopsies, 24 ± 6.8 echocardiograms, and 17 ± 4.4 clinic visits per recipient. During the 13-month period, 19 recipients had 24 treated rejection episodes, with the first at an average of 2.8 months post-transplant. The 3-, 12-, 36-, and 60-month conditional on discharge graft survival were 100%, 98.8%, 98.8%, and 90.4%, respectively, comparable to reported figures in major paediatric registries. At a mean follow-up of 4.7 ± 2.1 years, four patients (4.9%) developed cardiac allograft vasculopathy, three (3.7%) developed a malignancy, and seven (8.6%) suffered graft loss.Conclusion:Rejection surveillance with a low-intensity biopsy protocol demonstrated similar intermediate-term outcomes and safety measures as international registries up to 5 years post-transplant.


Sign in / Sign up

Export Citation Format

Share Document